Early Phase 1 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have had, or are planning to have, a liver biopsy as part of standard medical care for fatty liver disease with risk factors for a condition called MASH, OR as part of another clinical trial for MASH, OR as standard care before weight-loss (bariatric) surgery
- The liver biopsy must take place within 6 months of the study-related scans
- People who are able to give their informed consent to participate
Who may not be able to join:
- People with a history of alcohol abuse, hepatitis B, hepatitis C, or any other chronic liver disease apart from non-alcoholic fatty liver disease
- People with severe claustrophobia that is not controlled
- People who weigh more than 225 kg, due to the limits of the scanning equipment
- People who are pregnant or breastfeeding (a urine pregnancy test will be given before each PET/CT scan session to people aged 18–60 who could become pregnant, unless a documented hysterectomy is on record)
- People who have taken part in another research study involving a PET scan for research purposes within the last 12 months
- People who are currently imprisoned
- People with any other health condition that, in the opinion of the study doctor, could affect the goals of the trial
- People with an existing neurodegenerative disorder or dementia
- People with a significant history of a major skull concussion or repeated head injuries
- People who are currently taking blood-thinning (anticoagulant) medication
- People who have metal implants (such as a pacemaker) or claustrophobia that would prevent them from having an MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guobao Wang, PhD, UC Davis Health Department of Radiology
Phone: 916-734-7749
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
results of 18F-FDG scans compared with results of DPA-714 scans
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.